LAPTM5 and metabolic dysfunction-associated steatohepatitis: Given that NASH is the advanced stage of NAFLD, we fed Laptm5-Flox and Laptm5-HKO mice with an HFHC diet for 16 weeks to further explore the role of LAPTM5 in a mouse NASH model.